Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy

被引：0
|
作者：
O'Neal, Richard [1 ]
Roberts, Kandice [2 ]
Chen, Quan [2 ]
Huang, Bin [2 ]
Saeed, Hayder [3 ]
Ramlal, Reshma [3 ]
Monohan, Gregory [3 ]
Hildebrandt, Gerhard C. [3 ]
机构：
[1] Univ Kentucky, Hematol & Oncol, Lexington, KY USA
[2] Univ Kentucky, Lexington, KY USA
[3] Univ Kentucky, Markey Canc Ctr, Hematol & Blood & Marrow Transplant, Lexington, KY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
177
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies
    Timmers, Gert Jan
    van Vuurden, Dannis G.
    Swart, Eleonora L.
    Simoons-Smit, Alberdina M.
    Huijgens, Peter C.
    HAEMATOLOGICA, 2005, 90 (07) : 1005 - 1006
  • [42] Prognosis prediction of febrile neutropenia by MASCC score: A retrospective study
    Cervetti, Louise
    Vallard, Alexis
    Le Moulec, Sylvestre
    Espenel, Sophie
    Falk, Alexander Tuan
    Ben Mrad, Majed
    Guy, Jean-Baptiste
    Diao, Peng
    Mery, Benoite
    Langrand-Escure, Julien
    Ferrand, Francois-Regis
    Rivoirard, Romain
    Ceccaldi, Bernard
    Vedrine, Lionel
    Magne, Nicolas
    Chargari, Cyrus
    BULLETIN DU CANCER, 2016, 103 (06) : 561 - 570
  • [43] CISNE or MASCC, which predictor is really the weakest in febrile neutropenia?
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 50 : E33 - E34
  • [44] Antibiotic sequential therapy for febrile neutropenia in pediatric patients with malignancy
    Bernig, T
    Weigel, S
    Mukodzi, S
    Reddemann, H
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2000, 17 (01) : 93 - 98
  • [45] Effect of serum uric acid (ua) level and MASCC risk score on febrile neutropenia mortality
    Sutcuoglu, O.
    Akdogan, O.
    Inci, B. Kurt
    Gurler, F.
    Yildirim, N. Ozdemir
    Yazici, O.
    ANNALS OF ONCOLOGY, 2020, 31 : S1055 - S1055
  • [46] Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
    Luciano de Souza Viana
    José Carlos Serufo
    Manoel Otávio da Costa Rocha
    Renato Nogueira Costa
    Roberto Carlos Duarte
    Supportive Care in Cancer, 2008, 16 : 841 - 846
  • [47] Cumulative discontinuous neutropenia predicts risk of invasive Aspergillosis both during and after resolution of neutropenia in patients with hematologic malignancy
    Walker, R. C.
    Issa, N.
    Hoskin, T. L.
    St Sauver, J. L.
    Schleck, C. D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S72 - S72
  • [48] Febrile neutropenia in children treated for malignancy
    Barton, Chris D.
    Waugh, Lucy K.
    Nielsen, Maryke J.
    Paulus, Stephane
    JOURNAL OF INFECTION, 2015, 71 : S27 - S35
  • [49] Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
    Viana, Luciano de Souza
    Serufo, Jose Carlos
    da Costa Rocha, Manoel Otavio
    Costa, Renato Nogueira
    Duarte, Roberto Carlos
    SUPPORTIVE CARE IN CANCER, 2008, 16 (07) : 841 - 846
  • [50] Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients
    Koppaka, D.
    Kuntegowdanahalli, L. C.
    Lokanath, D.
    Babu, K. Govind
    Jacob, L. A.
    Babu, M. C. Suresh
    Lokesh, K. N.
    Rudresha, A. H.
    Rajeev, L. K.
    Smitha, S. C.
    Anand, A.
    Asati, V.
    Chethan, R.
    Patidar, R.
    Chaudhuri, T.
    Kasturi, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 129 - 129
12345